18
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Apaf-1, the CED-4 human homologue, an activator of caspase 3

Pages 1139-1142 | Published online: 25 Feb 2005

Bibliography

  • Zou H. HENZEL WJ, LIU X. LUTSCHG A, WANG X: apaf-1 a human protein homologous to c. elegans CED-4, participates in cytochrome c-dependent activation casepase-3. Cell (1997) 90(3):405–413.
  • LI P, NIJHAWAN D, BUDIHARDJO I et al.: Cytochrome cand dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 91 (4):479–489.
  • SLEE EA, HARTE MT, KLUCK RM et al.: Ordering thecytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell. Biol. (1999) 144(2) :281–292.
  • ZOU H, LI Y, LIU X, WANG X: An APAF-Lcytochrome cmultimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. (1 9 9 9) 274(17):11549–11556.
  • INOHARA N, KOSEKI T, DEL PESO L et al. : Nodl, anapaf-l-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. (1999) 274(21):14560–14567.
  • BERTIN J, NIR WJ, FISCHER CM et al.: Human CARD4protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB. J. Biol. Chem. (1999) 274 (19):12955–12958.
  • IMAI Y, KIMURA T, MURAKAMI A, YAJIMA N, SAKAMAKIK, YONEHARA S: The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature (1 9 9 9) 398(6730)777–785.
  • MUZIO M, CHINNAIYAN AM, KISCHKEL FC et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/AP0-1) death-inducing signaling complex. Cell (1996) 85(6):817–827.
  • MUZIO M, STOCKWELL BR, STENNICKE HR, SALVESEN GS, DIXIT VM: An induced proximity model for caspase-8 activation. J. Biol. Chem. (1 9 9 8) 273(5)2926–2930.
  • SUSIN SA, LORENZO HK, ZAMZAMI N et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (1999) 397(6718):441–446.
  • SUSIN SA, LORENZO HK, ZAMZAMI N et al.: Mitochon-drial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med. (1999) 189(2):381–394.
  • KRAJEWSKI S, KRAJEWSKA M, ELLERBY LM et al.: Releaseof caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. ScL USA (1999) 96(105752–5757.
  • SALEH A, SRINIVASULA SM, ACHARYA S, FISHEL R,ALNEMRI ES: Cytochrome c and dATP-mediated oligomerization of apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. (1999) 274 (25) :17941-17945. 1.ZOU H, HENZEL WJ, LIU X, LUTSCHG A, WANG X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell (1997) 90 (3):405–413.
  • ••Original paper identifying Apaf-1.
  • CHOU JJ, MATSUO H, DUAN H, WAGNER G: Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell (1998) 94 (2):171–180.
  • •The first structural elucidation of how CARD domains may interact.
  • HOFMANN K, BUCHER P, TSCHOPP J: The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. (1997) 22(5):155–156.
  • •Directed mining identifies the CARD motif and its presence within several apoptosis signaling molecules.
  • COSTANZO A, GUIET C, VITO P: c-E10 Is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB. J. Biol. Chem. (1999) 274(29)20127–20132.
  • SRINIVASULA SM, AHMAD M, LIN JH et al.: CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J. Biol. Chem. (1999) 274(25):17946–17954.
  • YAN M, LEE J, SCHILBACH S, GODDARD A, DIXIT V: mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J. Biol. Chem. (1999) 274(15)10287–10292.
  • QIN H, SRINIVASULA SM, WU G, FERNANDES-ALNEMRI T, ALNEMRI ES, SHI Y: Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature (1999) 399(6736):549–557.
  • ••Provides a structural basis for small molecule modeling ofcompounds designed to modulate Apaf- 1 -caspase 9 interactions.
  • REED JC, JURGENSMEIER JM, MATSUYAMA S: Bc1-2 family proteins and mitochondria. Biochim. Biophys. Acta (1998) 1366(1-2):127–137.
  • COSULICH SC, SAVORY PJ, CLARKE PR: Bc1-2 regulates amplification of caspase activation by cytochrome c. Curr. Biol. (1999) 9(3):147–150.
  • INOHARA N, GOURLEY TS, CARRIO R et al.: Diva, a Bc1-2 homologue that binds directly to Apaf-1 and induces BIB-independent cell death. J. Biol. Chem. (1998) 273 (49):32479–32486.
  • HU Y, BENEDICT MA, WU D, INOHARA N, NUNEZ G: Bc1-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. Natl. Acad. ScL USA (1998) 95(8):4386–4391.
  • YOSHIDA H, KONG YY, YOSHIDA R et al: Apafl is required for mitochondrial pathways of apoptosis and brain development. Cell (1998) 94(6):739–750.
  • •Demonstrates importance of Apaf-1 in normal brain morphogenesis.
  • CECCONI F, ALVAREZ-BOLADO G, MEYER BI, ROTH KA, GRUSS P: Apafl (CED-4 homolog) regulates programmed cell death in mammalian development. Cell (1998) 94(6):727–737.
  • •Highlights functional role of Apaf-1 in normal brain morphogenesis.
  • KUIDA K, ZHENG TS, NA S et al.: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (1996) 384(6607):368–372.
  • HAKEM R, HAKEM A, DUNCAN GS et al: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell (1998) 94(3):339–352.
  • •Elucidates role for caspase 9 in regulating cell numbers during morphogenesis.
  • KUIDA K, HAYDAR TF, KUAN CY et al.: Reduced apoptosis and cytochrome c-mediated caspase activa-tion in mice lacking caspase 9. Cell (1998) 94(3)325–337.
  • •Highlights importance of caspase 9 in normal brain morphogenesis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.